We are Axions
Let’s Change How We Care
Axio is a deep-science medical technology company with extensive expertise in biomaterials based medical devices for pre-hospital, intra-operative and post-operative clinical needs. Our focus is on devices for management of trauma, surgical and chronic wounds.
We bring together our biomaterials expertise with the contemporary knowledge of medicine and engineering to design novel solutions for management of trauma, surgical and chronic-infectious wounds.
Our flagship product, Axiostat, is a patented, clinically validated haemostat that stops moderate to severe bleeding instantly in surgeries and in pre-hospital trauma. Axiostat is USFDA 510(k) cleared and is also European CE approved.
In Advanced Wound Care range, Axio has launched the next-generation MaxioCel wound dressing. MaxioCel is designed to heal patients suffering from acute and chronic wounds (diabetic foot ulcers, pressure ulcers, burns, bed sores, cavity wounds and surgical site infections) by effectively managing exudates, pain reduction and scar less healing.
Axio has recently expanded its portfolio to include RESIST+ range of high-quality hygiene and protection solutions. RESIST+ range includes alcohol-based sanitizers, surface disinfectants, disinfecting wipes, and antimicrobial hand wash, manufactured under without any toxic chemicals.
All Axio products are manufactured in state-of-the-art ISO 13485 and GMP certified facility.
Axio intends to be the first choice for any customer looking for advanced wound care, hemostatic, and hygiene solutions worldwide and the company is positioned to upgrade wound care and hygiene care in both the institutional and consumer segments.
To Save, Improve and Touch lives of civilian and military victims, from uncontrolled hemorrhage by providing efficient solutions to stop bleeding through the use of innovative medical technology
To be the first choice of customers looking for advanced and affordable wound care solutions worldwide.